Stability‐indicating micelle‐enhanced spectrofluorimetric method for determination of loratadine and desloratadine in dosage forms
- 13 April 2011
- journal article
- research article
- Published by Wiley in Luminescence
- Vol. 26 (6) , 670-679
Abstract
A highly sensitive and simple spectrofluorimetric method was developed for the determination of loratadine (LRT) and desloratadine (DSL) in their pharmaceutical formulations. The proposed method is based on investigation of the fluorescence spectral behaviour of LRT and DSL in a sodium dodecyl sulphate (SDS) micellar system. In aqueous solution of acetate buffer of pH 4.5, the fluorescence intensities of both LRT and DSL were greatly enhanced (240%) in the presence of SDS. The fluorescence intensity was measured at 438 nm after excitation at 290 nm for both drugs. The fluorescence–concentration plots were rectilinear over the range 0.05–2.0 µg/mL for both LRT and DSL, with lower detection limits of 5.13 × 10−3 and 6.35 × 10−3 µg/mL for LRT and DSL, respectively. The method was successfully applied to the analysis of the two drugs in their commercial tablets, capsules and syrups, and the results were in good agreement with those obtained with the official or comparison methods. The proposed method is specific for the determination of LRT in the presence of other co‐formulated drugs, such as pseudoephedrine. The application of the proposed method was extended to stability studies of LRT and DSL after exposure to different forced degradation conditions, such as acidic, alkaline and oxidative conditions, according to ICH guidelines. Copyright © 2011 John Wiley & Sons, Ltd.Keywords
This publication has 30 references indexed in Scilit:
- A validated stability-indicating UPLC method for desloratadine and its impurities in pharmaceutical dosage formsJournal of Pharmaceutical and Biomedical Analysis, 2010
- Rapid separation of desloratadine and related compounds in solid pharmaceutical formulation using gradient ion-pair chromatographyJournal of Pharmaceutical and Biomedical Analysis, 2010
- Acid–base equilibria and solubility of loratadine and desloratadine in water and micellar mediaJournal of Pharmaceutical and Biomedical Analysis, 2009
- Development and validation of high-throughput liquid chromatography–tandem mass spectrometric method for simultaneous quantification of loratadine and desloratadine in human plasmaJournal of Chromatography B, 2007
- Determination of loratadine and its active metabolite in human plasma by high-performance liquid chromatography with mass spectrometry detectionJournal of Pharmaceutical and Biomedical Analysis, 2007
- Validated ion pair liquid chromatography/fluorescence detection method for assessing the variability of the loratadine metabolism occurring in bioequivalence studiesBiomedical Chromatography, 2007
- Simultaneous determination of loratadine and desloratadine in pharmaceutical preparations using liquid chromatography with a microemulsion as eluentJournal of Pharmaceutical and Biomedical Analysis, 2007
- Simple, Rapid, and Sensitive Spectrofluorimetric Determination of Zaleplon in Micellar MediumAnalytical Letters, 2003
- Simultaneous determination of pseudoephedrine sulfate, dexbrompheniramine maleate and loratadine in pharmaceutical preparations using derivative spectrophotometry and ratio spectra derivative spectrophotometryTalanta, 2000
- Micellar enhanced analytical fluorimetryTrAC Trends in Analytical Chemistry, 1984